Status:
RECRUITING
Validation of Accexible as a Tool for Screening and Monitoring Depression.
Lead Sponsor:
Accexible
Conditions:
Major Depressive Disorder (MDD)
Eligibility:
All Genders
18-65 years
Brief Summary
Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide. A recent orientation is the analysis of language ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adult 18-65 years of age.
- Participants must have Spanish as their first language (able to speak and understand verbal messages).
- Participants must have mobile phone with internet.
- Participants must have the ability to understand AcceXible's basic instructions.
- Participants must agree to participate in the study and have voluntarily signed the informed consent.
- Exclusion Criteria for patients:
- To have received a diagnosis of neurodegeneration.
- To have significant vision problems that would affect the ability to perceive visual stimuli.
- To have significant hearing problems that would affect the ability to understand verbal cues.
- To be unable to give informed consent to participate in the study.
Exclusion
Key Trial Info
Start Date :
January 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 3 2025
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT06044818
Start Date
January 22 2024
End Date
January 3 2025
Last Update
January 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vall d'Hebron Institut de Investigación (VHIR)
Barcelona, Spain, 08035